NCT01637662View on ClinicalTrials.gov

Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

January 31, 2014

Conditions
HeadacheMigraine
Interventions
DRUG

Natriuretic peptides

I.V. infusion between 0.2-3 microgram over 20 minutes

Trial Locations (1)

2600

Danish Headache Center, Copenhagen

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT01637662 - Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow | Biotech Hunter | Biotech Hunter